db/db마우스에서 Aspergillus awamori로 발효한 황기 추출물의 항당뇨 및 지질개선 효능
Anti-diabetic and Lipid Profile Effect of Astragalus membranaceus (Fisch.) Bunge Fermented by Aspergillus awamori in db/db Mice.
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
(Fisch.) Bunge fermented by Aspergillus awarmori in db/db mice. Methods and Results: Astragalus membranaceus roots were fermented with A. awarmori for 4 days and extracted with hot water. The male mice were divided into five groups: db/m (non-diabetic db/+mice), db/db (C57BLKs/J db/db mice), MT (db/db + 1% metformin), AM (db/db + 1% A. membranaceus extract), and FAM (db/db + 1% fermented A. membranaceus extract). After 10 weeks of treatment, we measured the body weight, food intake, and blood glucose, hemoglobin A1C (HbA1c), plasma insulin, adiponectin, and transaminase levels. Oral glucose tolerance test was performed and serum lipid profile was determined. As expected, the AM and FAM groups had significantly reduced body weight, fasting glucose, lipid content, and HbA1c, transaminase, and serum insulin levels, and increased serum adiponectin levels. Conclusions: Therefore, based on these research results, A. membranaceus extract and fermented A. membranaceus extract can be used to prevent and treat type 2 diabetes by reducing blood glucose levels and lipid content
Abstract
(Fisch.) Bunge fermented by Aspergillus awarmori in db/db mice. Methods and Results: Astragalus membranaceus roots were fermented with A. awarmori for 4 days and extracted with hot water. The male mice were divided into five groups: db/m (non-diabetic db/+mice), db/db (C57BLKs/J db/db mice), MT (db/db + 1% metformin), AM (db/db + 1% A. membranaceus extract), and FAM (db/db + 1% fermented A. membranaceus extract). After 10 weeks of treatment, we measured the body weight, food intake, and blood glucose, hemoglobin A1C (HbA1c), plasma insulin, adiponectin, and transaminase levels. Oral glucose tolerance test was performed and serum lipid profile was determined. As expected, the AM and FAM groups had significantly reduced body weight, fasting glucose, lipid content, and HbA1c, transaminase, and serum insulin levels, and increased serum adiponectin levels. Conclusions: Therefore, based on these research results, A. membranaceus extract and fermented A. membranaceus extract can be used to prevent and treat type 2 diabetes by reducing blood glucose levels and lipid content
참고문헌 (25)
- 배만종, "황기에 표고버섯 균사체를 배양한 추출물이 항암효과 및 알레르기 억제효과에 미치는 영향", 한국식품영양과학회지, 36(1), pp.8~13 (2007), 한국식품영양과학회
- Golay A, "Metformin and body weight", International Journal of Obesity, 32, pp.61~72 (2008)
- Harris EH, "Elevated liver function test in type 2 diabetes", Clinical Diabetes, 23, pp.115~119 (2003)
- 허진주, "당뇨 마우스에서 카르노신의 혈당강하 효과", 한국식품위생안전성학회지, 24(4), pp.391~397 (2009), 한국식품위생안전성학회
- 한지숙, "조릿대잎 추출물의 탄수화물 소화효소활성 저해 및 식후혈당강하효과", 한국식품영양과학회지, 36(8), pp.989~994 (2007), 한국식품영양과학회
- 제갈준미, "황기 추출물을 첨가한 양념 치킨 소스의 품질 특성", 동아시아식생활학회지, 29(5), pp.383~391 (2019), 동아시아식생활학회[DOI]
- Kadowaki T, "Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome", Journal of Clinical Investigation, 116, pp.1784~1792 (2006)
- 김철중, "β-glucosidase 활성 균주 발효에 의한 황기 Isoflavonoid 성분변화 및 생리활성", 한국약용작물학회지, 28(5), pp.371~378 (2020), 한국약용작물학회[DOI]
- 김남석, "당뇨병 마우스(db", db) 모델에서 삼채(Allium Hookeri) 부위별 추출물의 항당뇨 효능 연구, 2016, pp.47(2), 158~164[DOI]
- Kim OK, "Antidibetic effect of ethanol extract on Astragali Radix", Journal of the Korean Applied Science and Technology, 26, pp.898~904 (2019)
- 권한올, "홍삼추출물(KGC05P0)이 고인슐린혈증 제2형 당뇨병 마우스에서 인슐린 민감성, 인슐린 분비량 및 혈당 조절에 미치는 영향", 한국식품영양과학회지, 49(6), pp.539~546 (2020), 한국식품영양과학회[DOI]
- 이은정, "Aspergillus awamori로 발효한 황기 열수 추출물의 이화학적 특성과 항염증 효과", 한국약용작물학회지, 28(5), pp.347~353 (2020), 한국약용작물학회[DOI]
- 이준형, "유산균을 이용한 홍고추의 발효를 통한 항비만과 항당뇨 효과", 생명과학회지, 29(3), pp.354~361 (2019), 한국생명과학회[DOI]
- 이연리, "C57BL", KsJ-db, 한국식품영양과학회지, pp.2012, 41(3)[DOI]
- Liu J, "Review of Astragali radix", Chinese Herbal Medicines, 3, pp.90~105 (2011)
- Min KH, "Ishige okamurae ameliorates hyperglycemia and insulin resistance in C57BL", KsJ-db, Diabetes Research and Clinical Practice, pp.2011, 93[DOI]
- 오다영, "울금(Curcuma longa L.) 첨가 식이가 이상지질혈증 흰쥐의 지질성분 및 단백질 농도에 미치는 영향", 한국응용과학기술학회지, 36(1), pp.47~58 (2019), 한국응용과학기술학회
- 박지희, "갈근에서 분리한 화합물의 α-glucosidase와 α-amylase 활성 저해 효과", 한국약용작물학회지, 17(5), pp.357~362 (2009), 한국약용작물학회
- Pruessner JC, "Two fomulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change", Psychoneroendocrinology, 28, pp.916~931 (2003)
- Sherwani SI, "Significance of HbA1c test in diagnosis and prognosis of diabetic patients", Biomarker Insights, 11, pp.95~104 (2016)
- Wilcox G, "Insulin and insulin resistance", The Clinical Biochemist Review, 26, pp.19~39 (2005)
- Xiao C, "Pharmacological targeting of the atherogenic dyslipidemia complex : The next frontier in CVD prevention beyond lowering LDL cholesterol", Diabetes, 65, pp.1767~1778 (2016)
- 윤우준, "혈당관리 수준과 당뇨병성 망막증과의 관련성", Annals of geriatric medicine and research, 14(4), pp.234~241 (2010), 대한노인병학회
- Zhang L, "Astragalus membranaceus(Huang Qi)as adjunctive therapy for diabetic kidney disease : An updated systematic review and meta-analysis", Journal of Ethnopharmacology, 239, pp.111921~ (2019)[DOI]
- Zhou X, "Renal protective effects of astragaloside Ⅳ, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis", Pharmacological Research, 160(105192) (2020)[DOI]